Qingqing Mao

Dr. Qingqing Mao

Metabolomics, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Open access
JFJulia Fritsch
Julia Fritsch
LGLuis Garces
Luis Garces
MQMaria A. Quintero
Maria A. Quintero
JPJudith Pignac-Kobinger
Judith Pignac-Kobinger
ASAna M. Santander
Ana M. Santander
MAMaria T. Abreu
Maria T. Abreu
A high-fat diet has been associated with an increased risk of ulcerative colitis (UC). We studied the effects of a low-fat, high-fiber diet (LFD) vs an improved standard American diet (iSAD, included higher quantities of fruits, vegetables, and fiber than a typical SAD). We collected data on quality of life, markers of inflammation, and fecal markers of intestinal dysbiosis in patients with UC. We analyzed data from a parallel-group, cross-over study of 17 patients with UC in remission or with mild disease (with a flare within the past 18 mo), from February 25, 2015, through September 11, 2018. Participants were assigned randomly to 2 groups and received a LFD (10% of calories from fat) or an iSAD (35%-40% of calories from fat) for the first 4-week period, followed by a 2-week washout period, and then switched to the other diet for 4 weeks. All diets were catered and delivered to patients' homes, and each participant served as her or his own control. Serum and stool samples were collected at baseline and week 4 of each diet and analyzed for markers of inflammation. We performed 16s ribosomal RNA sequencing and untargeted and targeted metabolomic analyses on stool samples. The primary outcome was quality of life, which was measured by the short inflammatory bowel disease (IBD) questionnaire at baseline and week 4 of the diets. Secondary outcomes included changes in the Short-Form 36 health survey, partial Mayo score, markers of inflammation, microbiome and metabolome analysis, and adherence to the diet. Participants' baseline diets were unhealthier than either study diet. All patients remained in remission throughout the study period. Compared with baseline, the iSAD and LFD each increased quality of life, based on the short IBD questionnaire and Short-Form 36 health survey scores (baseline short IBD questionnaire score, 4.98; iSAD, 5.55; LFD, 5.77; baseline vs iSAD, P = .02; baseline vs LFD, P = .001). Serum amyloid A decreased significantly from 7.99 mg/L at baseline to 4.50 mg/L after LFD (P = .02), but did not decrease significantly compared with iSAD (7.20 mg/L; iSAD vs LFD, P = .07). The serum level of C-reactive protein decreased numerically from 3.23 mg/L at baseline to 2.51 mg/L after LFD (P = .07). The relative abundance of Actinobacteria in fecal samples decreased from 13.69% at baseline to 7.82% after LFD (P = .017), whereas the relative abundance of Bacteroidetes increased from 14.6% at baseline to 24.02% on LFD (P = .015). The relative abundance of Faecalibacterium prausnitzii was higher after 4 weeks on the LFD (7.20%) compared with iSAD (5.37%; P = .04). Fecal levels of acetate (an anti-inflammatory metabolite) increased from a relative abundance of 40.37 at baseline to 42.52 on the iSAD and 53.98 on the LFD (baseline vs LFD, P = .05; iSAD vs LFD, P = .09). The fecal level of tryptophan decreased from a relative abundance of 1.33 at baseline to 1.08 on the iSAD (P = .43), but increased to a relative abundance of 2.27 on the LFD (baseline vs LFD, P = .04; iSAD vs LFD, P = .08); fecal levels of lauric acid decreased after LFD (baseline, 203.4; iSAD, 381.4; LFD, 29.91; baseline vs LFD, P = .04; iSAD vs LFD, P = .02). In a cross-over study of patients with UC in remission, we found that a catered LFD or iSAD were each well tolerated and increased quality of life. However, the LFD decreased markers of inflammation and reduced intestinal dysbiosis in fecal samples. Dietary interventions therefore might benefit patients with UC in remission. ClinicalTrials.gov no: NCT04147598.

11 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
PDPrasad P Devarshi
Prasad P Devarshi
Qingqing MaoQingqing Mao
Qingqing Mao
RGRyan W. Grant
Ryan W. Grant
SMSusan Mitmesser
Susan Mitmesser
Zinc is an essential micronutrient that is needed for numerous critical health functions in the body. It is estimated that 17 to 20% of the global population is at risk for zinc deficiency, with certain groups at higher risk. The provision of supplemental zinc is a convenient and effective option for treating zinc deficiency and maintaining healthy levels of zinc. Several zinc salts are available for use in supplements. However, little information is available comparing the absorption and bioavailability of these different chemical forms of zinc. In this narrative review, we provide an overview of zinc absorption and bioavailability, discuss indicators of zinc status and risk factors for zinc deficiency, and review clinical studies comparing the absorption and bioavailability of different chemical forms of zinc in humans. This review of the clinical evidence suggests that zinc glycinate and zinc gluconate are better absorbed than other forms of zinc.

1 August 2019 in Food Chemistry
Verified
Journal Article
Closed access
DCDongjie Chen
Dongjie Chen
PPPeng Peng
Peng Peng
NZNan Zhou
Nan Zhou
YCYanling Cheng
Yanling Cheng
MMMin Min
Min Min
RRRoger Ruan
Roger Ruan

21 December 2022 in Innovative Food Science & Emerging Technologies
Verified
Journal Article
Closed access
FBFan Bu
Fan Bu
SFSamira Feyzi
Samira Feyzi
GNGaurav Nayak
Gaurav Nayak
Qingqing MaoQingqing Mao
Qingqing Mao
VKV.S. Santosh K. Kondeti
V.S. Santosh K. Kondeti
BIBaraem P. Ismail
Baraem P. Ismail

1 December 2018 in Journal of Food Engineering
Verified
Journal Article
Closed access
DCDongjie Chen
Dongjie Chen
JWJustin Wiertzema
Justin Wiertzema
PPPeng Peng
Peng Peng
YCYanling Cheng
Yanling Cheng
JLJuer Liu
Juer Liu
RRRoger Ruan
Roger Ruan

13 April 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
JKJinshil Kim
Jinshil Kim
MPMyungseo Park
Myungseo Park
EAEunbyeol Ahn
Eunbyeol Ahn
Qingqing MaoQingqing Mao
Qingqing Mao
Chi ChenChi Chen
Chi Chen
Byeonghwa JeonByeonghwa Jeon
Byeonghwa Jeon
Oxygen-sensitive foodborne pathogens must withstand oxygen toxicity in aerobic environments during transmission to humans. C. jejuni is a major cause of gastroenteritis, accounting for 400 million to 500 million infection cases worldwide per year. As an obligate microaerophile, C. jejuni is sensitive to air-level oxygen.